Colleen Burgess
Biographic Data
| ID | 9064942 |
|---|---|
| NAME | Colleen Burgess |
| GIVEN NAMES | Colleen |
| FAMILY NAME | Burgess |
| SIGNATURE | BURGESS C |
| AFFILIATIONS | Merck & Co., Inc., Rahway, NJ, USA (United States) |
| ORCID | 0000-0003-0393-0767 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
BACKGROUND: Since 2000, the incidence of measles and rubella has declined as measles-rubella (MR) vaccine coverage increased due to intensified routine immunisation (RI) and supplementary immunisation activities (SIAs). The World Health Assembly commissioned a feasibility assessment of eliminating measles and rubella. The objective of this paper is to present the findings of cost-effectiveness analysis (CEA) of ramping up MR vaccination with a go…
Universal varicella vaccination in Denmark
We modeled the long-term clinical and economic impact of two-dose universal varicella vaccination (UVV) strategies in Denmark using a dynamic transmission model. The cost-effectiveness of UVV was evaluated along with the impact on varicella (including age-shift) and herpes zoster burden. Six two-dose UVV strategies were compared to no vaccination, at either short (12/15 months) or medium (15/48 months) intervals. Monovalent vaccines (V-MSD or V-G…
No prominent works on this page.
Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
BACKGROUND: Since 2000, the incidence of measles and rubella has declined as measles-rubella (MR) vaccine coverage increased due to intensified routine immunisation (RI) and supplementary immunisation activities (SIAs). The World Health Assembly commissioned a feasibility assessment of eliminating measles and rubella. The objective of this paper is to present the findings of cost-effectiveness analysis (CEA) of ramping up MR vaccination with a go…
Universal varicella vaccination in Denmark
We modeled the long-term clinical and economic impact of two-dose universal varicella vaccination (UVV) strategies in Denmark using a dynamic transmission model. The cost-effectiveness of UVV was evaluated along with the impact on varicella (including age-shift) and herpes zoster burden. Six two-dose UVV strategies were compared to no vaccination, at either short (12/15 months) or medium (15/48 months) intervals. Monovalent vaccines (V-MSD or V-G…
Immunology (2 works) · Medicine (2 works) · Pediatrics (2 works) · Vaccination (2 works) · Bartonella species infections research (1 work) · Congenital rubella syndrome (1 work) · Environmental health (1 work) · Hepatitis Viruses Studies and Epidemiology (1 work) · Herpesvirus Infections and Treatments (1 work) · Immune responses and vaccinations (1 work)